10x Genomics (TXG) Return on Capital Employed (2019 - 2026)
10x Genomics recorded quarterly Return on Capital Employed of 4.23% in Q1 2026, up 38.9% quarter-over-quarter from 6.92% in Q4 2025, and up 1724.0% year-over-year from 0.23% in Q1 2025.
10x Genomics' Return on Capital Employed history runs 8 years deep, the most recent figure standing at 4.23% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 1724.0% year-over-year to 4.23%; the TTM figure through Mar 2026 stood at 4.23% (up 1724.0% YoY), while the FY2025 annual figure was 7.38%, up 1623.0% from the prior year.
- Return on Capital Employed came in at 4.23% for Q1 2026 at 10x Genomics, up from 6.92% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4.23% in Q1 2026 to a low of 32.9% in Q1 2024.
- A 5-year average of 19.31% and a median of 19.59% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed jumped 5473 bps in 2022 and tumbled 1331 bps in 2024, its largest moves.
- 10x Genomics' Return on Capital Employed stood at 19.05% in 2022, then plunged by 68 bps to 31.98% in 2023, then increased by 25 bps to 24.0% in 2024, then surged by 71 bps to 6.92% in 2025, then soared by 39 bps to 4.23% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 4.23%, 6.92%, and 10.66% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 13.28% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.09% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -163.65% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 21.81% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 4.73% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -4.23% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 4.60% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 2.23% |
| 10 | Teladoc Health | 1.42 Bn | 672.39 Mn | 562.57 Mn | -8.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.23% |
| Dec 31, 2025 | -6.92% |
| Sep 30, 2025 | -10.66% |
| Jun 30, 2025 | -12.12% |
| Mar 31, 2025 | -21.47% |
| Dec 31, 2024 | -24.00% |
| Sep 30, 2024 | -24.60% |
| Jun 30, 2024 | -31.06% |
| Mar 31, 2024 | -32.90% |
| Dec 31, 2023 | -31.98% |
| Sep 30, 2023 | -26.98% |
| Jun 30, 2023 | -19.74% |
| Mar 31, 2023 | -19.59% |
| Dec 31, 2022 | -19.05% |
| Sep 30, 2022 | -18.43% |
| Jun 30, 2022 | -15.44% |
| Mar 31, 2022 | -9.14% |
| Dec 31, 2021 | -5.84% |
| Sep 30, 2021 | -50.47% |
| Jun 30, 2021 | -58.10% |
| Mar 31, 2021 | -63.87% |
| Dec 31, 2020 | -61.55% |
| Sep 30, 2020 | -19.88% |
| Jun 30, 2020 | -16.12% |
| Mar 31, 2020 | -8.64% |
| Dec 31, 2019 | -5.81% |